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Objectives. In this study we used a population-based approach
to assess the impact of fetal echocardiography on a well deﬁned
birth population with nearly complete ascertainment of cardiac
defects.
Background. Although fetal echocardiography is being used
more frequently in the prenatal diagnosis of congenital cardiac
malformations, its impact on the diagnosis and surveillance of
cardiac defects has not been described in deﬁned populations.
Methods. All stillborn and live-born infants with diagnosed
cardiac defects and whose mothers resided in the metropolitan
Atlanta area from January 1990 through December 1994 were
ascertained through an established birth defects surveillance
system. All fetuses with cardiac defects diagnosed prenatally by a
pediatric cardiologist were identiﬁed from clinical records. The
spectrum of cardiac defects, diagnostic trends and adverse fetal
outcomes were described.
Results. We identiﬁed 1,589 infants with congenital cardiac
malformations, for a live-birth prevalence rate of 8.1/1,000 (95%
conﬁdence interval [CI] 7.8 to 8.6). Overall, 97 (6.1%) of these
cases of cardiac malformations were diagnosed prenatally. The
proportion of cardiac defects diagnosed prenatally rose from 2.6%
in 1990 to 12.7% in 1994, a nearly ﬁvefold increase. The propor-
tion of cardiac defects diagnosed prenatally during the study
varied by the type of defect, from a low of 4.7% for atrial septal
defects to a high of 28% for hypoplastic left heart syndrome.
Prenatally diagnosed cardiac malformations were associated with
a high incidence of infant mortality (30.9%, 95% CI 2.4 to 5.4) and
fetal wastage (17.5%, 95% CI 6.2 to 11.3).
Conclusions. These data show that fetal echocardiography is
being used increasingly in the prenatal diagnosis of congenital
cardiac malformations in metropolitan Atlanta. Few pregnancy
terminations were reported as a result of such diagnoses. How-
ever, the study had limited power (10%) to detect a meaningful
decrease in birth prevalence rates for congenital heart disease. In
addition, survival of infants was not improved after prenatal
diagnosis with fetal echocardiography.
(J Am Coll Cardiol 1996;28:1805–9)
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The use of fetal echocardiography to diagnose congenital
cardiac malformations prenatally is rapidly becoming the stan-
dard of care in most large pediatric cardiology centers (1,2).
Centers routinely performing fetal echocardiography are mak-
ing earlier diagnoses of more complex cardiac malformations,
associated extracardiac anomalies and intrauterine cardiac
failure, all of which lead to poor fetal outcomes (1–3). Multi-
specialty teams consisting of pediatric cardiologists, perina-
tologists and obstetricians are rapidly evolving to manage these
more frequently identiﬁed high risk pregnancies with hemody-
namically signiﬁcant congenital cardiac malformations.
Fetal echocardiography resulting from referral after screen-
ing obstetrical ultrasound is being used increasingly to diag-
nose the complete prenatal spectrum of congenital cardiac
malformations and to predict fetal outcomes. Nevertheless, the
impact of fetal echocardiography on the prenatal diagnosis of
congenital cardiac malformations has not been described in
well deﬁned birth populations.
The purpose of this study was to use a population-based
approach to assess the proportion of pregnancies in which a
prenatal diagnosis of congenital cardiac malformations was
made by fetal echocardiography. We did this to evaluate the
impact of this technology on the measured birth prevalence of
cardiac malformations. We also compared the frequencies of
cardiac malformations, associated noncardiac malformations
and fetal outcomes among pregnant women who had a prena-
tal diagnosis by fetal echocardiography with those who did not.
Methods
Patient population. All infants born from January 1990
through December 1994 and diagnosed with a congenital
cardiac malformation were registered by the Metropolitan
Atlanta Congenital Defects Program (MACDP). Since 1967,
From the Birth Defects and Genetic Diseases Branch, National Center for
Environmental Health, Centers for Disease Control and Prevention; and *The
Children’s Heart Center, Department of Pediatrics, Emory University School of
Medicine, Atlanta, Georgia.
Manuscript received April 8, 1996; revised manuscript received May 31,
1996, accepted August 14, 1996.
Address for correspondence: Dr. Eduardo Montan˜a, The Children’s Heart
Center, 2040 Ridgewood Drive, NE, Atlanta, Georgia 30322.
JACC Vol. 28, No. 7
December 1996:1805–9
1805
1996 by the American College of Cardiology 0735-1097/96/$15.00
Published by Elsevier Science Inc. PII S0735-1097(96)00381-6
MACDP has been an ongoing, population-based surveillance
system for birth defects, with active case ascertainment. Details
of the program have been described elsewhere (4,5).
The following criteria must be fulﬁlled to meet the MACDP
case deﬁnition of a congenital defect: 1) the mother must be a
resident of the ﬁve-county metropolitan Atlanta area (Cobb,
Clayton, Decatur, Fulton and Gwinnett) at the time of birth; 2)
the baby must have a gestational age of at least 20 weeks or a
birth weight of at least 500 g; 3) the baby must have a structural
or chromosomal defect that can adversely affect his or her
health or development; 4) the diagnosis must be made or
symptoms must be present in the child’s ﬁrst year of life; and
5) the case must be abstracted by the child’s sixth birthday.
Although MACDP may not detect minor birth defects among
infants not requiring hospital care, we believe it does provide
near complete ascertainment for most congenital cardiac de-
fects.
Referrals for fetal echocardiography. All referrals for pre-
natal diagnoses of congenital cardiac malformations made by
using fetal echocardiography were identiﬁed by a retrospective
review of the clinical records of The Children’s Heart Center at
the Emory University School of Medicine. Because this center
is the only pediatric cardiology center in the Atlanta area,
providing services for infants born with serious cardiac malfor-
mations, the records were considered complete. Previously,
Emory University School of Medicine has contributed clinical
information on other congenital malformations to the
MACDP surveillance system.
Fetal outcomes. After a prenatal diagnosis by fetal echo-
cardiography was made, outcome data, including all live-births,
stillbirths, spontaneous and induced abortions at 20 weeks’
gestation and at least 500 g birth weight and death before 5
years of age, were obtained from the MACDP surveillance
system. Pregnancy terminations before 20 weeks were not
actively ascertained in the MACDP surveillance data; however,
an incomplete and passive recording system of induced abor-
tions is maintained. Therefore, unrecognized pregnancy termi-
nations were actively sought from available hospital perinatol-
ogy and cardiology records. These data were used to test the
hypothesis that early prenatal diagnosis of cardiac defects does
not favorably affect fetal outcome.
Statistical analysis. We compared available demographic
and clinical data of the subjects known to have had a prenatal
diagnosis using fetal echocardiography at The Children’s Heart
Center and all subjects identiﬁed in MACDP as having cardiac
malformations. Comparison groups were created from existing
surveillance data using SAS Systems software (SAS Institute
Inc.), and univariate analysis was performed. Subjects were
compared with respect to demographics, cardiac malforma-
tions, noncardiac malformations, syndromes and fetal out-
comes. We compared the frequency of diagnoses and yearly
trends with and without prenatal diagnosis. Cardiac malforma-
tions were grouped by presumed pathogenetic mechanisms
using the classiﬁcation of Clark (6), a developmental approach
to classifying cardiac malformations. We performed the chi-
square test for linear trends using the extended Mantel-
Haenszel method that accompanies Epi Info Software 6.0
(Centers for Disease Control and Prevention).
Results
Patient demographics. During the 5-year study period,
1,589 infants registered in MACDP had a diagnosis of congen-
ital cardiac malformation. During this same period, there were
194,754 total live births in the Atlanta area, resulting in a birth
prevalence of 8.1 cases/1,000 live births (95% conﬁdence
interval [CI] 7.8 to 8.6). Of the 1,589 infants with congenital
cardiac malformations, 97 (6.1%) had their malformation
diagnosed prenatally with fetal echocardiography (Table 1).
Overall, when classiﬁed by race, subjects with a congenital
cardiac malformation diagnosed prenatally were signiﬁcantly
less likely to be classiﬁed as “white” and more likely to be
classiﬁed as “other race” when compared with all subjects with
cardiac defects. There were no signiﬁcant gender differences
between the subjects diagnosed prenatally and those who were
not.
The proportion of subjects with a congenital cardiac mal-
formation diagnosed prenatally increased from 2.6% in 1990 to
12.7% in 1994 (Fig. 1).
The average estimated gestational age at the time of
prenatal diagnosis by fetal echocardiography was shown to
decrease during the study period, from 28.7 weeks in 1990 to a
low of 24.6 weeks in 1993 (p  0.05) (Fig. 2).
Cardiac lesions diagnosed prenatally. The proportion of
cardiac malformation cases that were prenatally diagnosed is
shown by the developmental and anatomic groups (according
to the Clark classiﬁcation [6]) in Table 2. Of 57 cases of
hypoplastic left heart syndrome diagnosed during the study
period, 28% were diagnosed prenatally. The proportion of
other major cardiac malformations that were diagnosed pre-
natally included atrioventricular septal defects (16.3%), trun-
Table 1. Selected Sociodemographic Characteristics of All Subjects
With a Congenital Cardiac Malformation and Those With Prenatally
Diagnosed Malformations, Atlanta, Georgia, 1990–1994
Characteristic
All
Subjects
[no. (%)]
Prenatally
Diagnosed Subjects
[no. (%)]
Total 1,589 (100) 97 (6.1)
Race
White 807 (50.9) 37* (38.1)
Black 667 (41.9) 42 (43.3)
Other 115 (7.2) 18† (18.6)
Gender
Male 865 (54.4) 60 (61.8)
Female 724 (45.6) 37 (38.2)
Maternal age (yr)
20 156 (9.8) 8 (8.21)
20–29 811 (51.1) 47 (48.5)
30–34 388 (24.4) 23 (23.7)
35 234 (14.7) 19 (19.6)
*p  0.05 (95% conﬁdence interval [CI] 0.62 to 0.92). †p  0.001 (95% CI
2.92 to 5.19).
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cus arteriosus (15%), single ventricle (14.2%), tetralogy of
Fallot (13.6%), anomalous systemic veins (11%) and tricuspid
valve anomalies (9.1%). Ventricular septal defects and atrial
septal defects, with postnatal prevalence rates, as reported by
MACDP, of 2.7 (95% CI 2.3 to 2.8) and 3.91 (95% CI 3.6 to
4.2) cases per 1,000 live births, respectively, were each diag-
nosed prenatally in 5% of cases with malformations.
Trends in diagnosis by year. An analysis of trends in the
referrals for fetal echocardiographic prenatal diagnosis of
selected cardiac malformations is shown in Figure 3. Over the
5-year study period, increasing percentages of major congeni-
tal cardiac malformations were diagnosed by fetal echocardi-
ography. During 1990, only 18.8% of all subjects with hypo-
plastic left heart syndrome had the syndrome diagnosed
prenatally. This proportion increased to 40% during 1994 (p 
0.05). Similar increasing trends in prenatal diagnosis were
shown for all types of cardiac malformations: tricuspid valve
stenosis/atresia (3.5% to 14%), great vein anomalies (1% to
13.6%), pulmonary valve stenosis/atresia (2.4% to 12.5%),
aortic arch stenosis/atresia (1.8% to 16.3%), atrial septal
Figure 1. Proportion of all cardiac defects diagnosed prenatally by
fetal echocardiography, Atlanta, Georgia, 1990–1994.
Figure 2. Average estimated gestational age at prenatal diagnosis by
year, Atlanta, Georgia, 1990–1994.
Table 2. Subjects With Speciﬁc Types of Congenital Cardiac
Malformations Who Were Diagnosed Prenatally, Atlanta, Georgia
1990–1994
Developmental Category
All Subjects
(n  1,589)
(no.)
Prenatally Diagnosed
Subjects
(n  97)
[no. (%)]*
Ectomesenchymal tissue migration
defects
Tetralogy of Fallot 66 9 (13.6)
Transposition of great arteries 80 5 (6.3)
Truncus arteriosus 13 2 (15.0)
Targeted growth defects
Anomalous systemic veins 164 18 (11.0)
Hemodynamic defects, right sided
Pulmonary artery stenosis/atresias 180 9 (5.0)
Hemodynamic defects, left sided
Hypoplastic left heart syndrome 57 16 (28.0)
Aortic arch hypoplasia/atresias 146 11 (7.5)
Aortic valve stenosis/atresias 92 8 (8.7)
Mitral valve stenosis/atresias 123 11 (8.9)
Extracellualar matrix/cell death defects
Atrioventricular septal defects† 80 13 (16.3)
Tricuspid valve stenosis/atresias‡ 404 37 (9.1)
Single ventricle§ 12 2 (14.2)
Atrial septal defects 761 36 (4.7)
Ventricular septal defects 486 24 (4.9)
Congenital heart block 43 3 (7.0)
*Percentages do not equal 100% because some subjects have multiple
defects. †Includes ostium primum atrial septal defects. ‡Includes Ebstein’s
anomaly, stenosis and atresias; anomalies of tricuspid valve not differentiated in
surveillance data. §Excludes tricuspid valve atresia with dominant ventricle; may
include other functionally single ventricles where a rudimentary or hypoplastic
ventricle exists.
Figure 3. Major trends in prenatal diagnosis of total and selected
congenital cardiac malformations, Atlanta, Georgia, 1990–1994.
ASD  atrial septal defect; HLHS  hypoplastic left heart syndrome;
VSD  ventricular septal defect.
1807JACC Vol. 28, No. 7 MONTAN˜A ET AL.
December 1996:1805–9 POPULATION TRENDS OF FETAL CONGENITAL HEART DISEASE
defects (2.3% to 11%) and ventricular septal defects (2% to
10.9%).
Noncardiac malformations. Subjects with and without car-
diac malformations diagnosed prenatally were grouped accord-
ing to the presence of noncardiac malformations and syn-
dromes (Table 3). The majority in both groups presented with
isolated cardiac anomalies. Furthermore, the two groups did
not differ signiﬁcantly with respect to other associated anom-
alies. The most common noncardiac malformations among the
prenatally diagnosed group were musculoskeletal anomalies
(10.9%), central nervous system anomalies (10%) and esoph-
ageal/upper gastrointestinal atresia (11.8%). However, most
types of major noncardiac malformations were represented.
Major chromosomal anomalies were also seen among the
prenatally diagnosed infant group, with frequent diagnoses of
trisomy 18 and 21 (six cases each) and autosomal deletions
(ﬁve cases) reported.
Fetal outcomes. Outcomes, as assessed from the surveil-
lance reporting system after prenatal diagnosis of congenital
cardiac malformation, are shown in Table 4. Most fetuses
(82.5%) with a prenatal diagnosis of cardiac malformation
developed and survived birth. Among fetuses with diagnosed
cardiac malformations, 32.9% were born premature and 59.8%
were born small for their gestational age (p  0.01). Of the
infants whose defect was diagnosed prenatally, 30.9% (p 
0.01) died before 5 years of age, and almost 10% were
stillborn, reﬂecting the severity of the conditions. In the total
study population, only 10% of infants with a cardiac malfor-
mation died before age 5 years, and only 2% were stillborn. In
8.2% of the prenatally diagnosed cases of cardiac malforma-
tions, the women involved chose to have induced abortions.
Discussion
In this study we showed that the spectrum of defects
diagnosed by fetal echocardiography differs markedly from
that diagnosed postnatally, and that prenatal diagnoses are
being made earlier every year (average 24.6 weeks’ gestation).
These diagnoses tended to be more severe and complex and
were associated with a higher frequency of prematurity, low
birth weight and adverse pregnancy outcomes, including fetal
wastage and early childhood mortality, than were cardiac
malformations diagnosed postnatally in the birth population.
Prenatal referrals for fetal echocardiography. During the
study period, the Atlanta area, as reported by the MACDP
surveillance system and the regional cardiology center, expe-
rienced a rapid rise in the proportion of infants with congenital
cardiac malformations who were referred for prenatal diagno-
sis. This was attributable mostly to an expanding pediatric
cardiology, obstetric and perinatology provider network in
Atlanta during the study period. In addition, increased educa-
tion and awareness by the obstetric community may have
increased early referrals for fetal cardiovascular assessment.
Many centers where fetal echocardiography is the estab-
lished standard of care cite active training of community
obstetric ultrasonographers in basic fetal cardiac imaging
techniques as the main reason for increased early recognition
of fetal congenital cardiac malformations (1,5).
Associated noncardiac malformations. The ﬁnding of fre-
quent associated noncardiac defects and syndromes among
infants with congenital cardiac malformations diagnosed pre-
natally has been reported previously by several centers (2,3). In
addition, it is recognized that the presence of both extra
cardiac anomalies and prenatal cardiac failure substantially
increases prenatal and postnatal mortality among these infants
(6). This study further supports the notion that prenatally
diagnosed congenital heart disease carries a poor prognosis.
Study limitations. The true incidence of congenital cardiac
malformations within a birth population can only be deter-
mined with the complete ascertainment of all fetal outcomes
(i.e., live births, stillbirths, spontaneous abortions and induced
abortions); this ascertainment process should include the
inspection of all products of fetal wastage. We were unable to
completely ascertain all fetal outcomes in the present study,
primarily because spontaneous and induced abortions 20
weeks’ gestation were not regularly documented by the surveil-
lance system.
Although we found that a small proportion of pregnancies
involving prenatally diagnosed congenital cardiac malforma-
tions were terminated, the total number of induced abortions
with cardiac defects captured by the surveillance system was
probably underestimated because not all products of concep-
tion were examined. In addition, some pregnancies with fetal
Table 3. Subjects With Congenital Cardiac Malformations Who
Were Diagnosed Prenatally and Classiﬁed by the Presence of
Associated Anomalies and Syndromes, Atlanta, Georgia, 1990–1994
Defect Group
All Subjects
(n  1,589)
[no. (%)]
Prenatally Diagnosed
(n  97)
[no. (%)]
Isolated cardiac anomalies 823 (51.8) 46 (47.4)
Multiple major anomalies 560 (35.2) 34 (35.1)
Chromosomal syndromes* 206 (13) 17 (17.5)
*Included six cases of trisomy 21, six of trisomy 18 and ﬁve of other
autosomal disorders.
Table 4. Pregnancy Outcomes of Subjects With Congenital Cardiac
Malformation Prenatally Diagnosed With Fetal Echocardiography,
Atlanta, Georgia, 1990–1994
Outcome No. (%) RR (95% CI)
Live-born 80 (82.5) NS
Premature* 32 (32.9) NS
SGA† 58 (59.8) NS
Died in 5 yr 30 (30.9)‡ 3.6 (2.4–5.4)
Induced abortion§ 8 (8.2)‡ 8.4 (6.2–11.3)
Stillborn¶ 9 (9.3)‡ 5.1 (2.8–9.3)
Total 97 (100)
*Born before 36 weeks’ gestation. †Small for gestational age. ‡p  0.05
versus total group of subjects with heart defects. §Termination before 20 weeks’
gestation. ¶Stillborn after 20 weeks’ gestation or birth weight 500 g. CI 
conﬁdence interval; RR  relative risk; SGA  small for gestational age.
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cardiac malformations may have been recognized and, if
severe, terminated by obstetricians without referral to a pedi-
atric cardiologist for fetal echocardiography.
Nevertheless, because the birth prevalence of congenital
cardiac malformations has remained relatively stable, at 8
cases/1,000 live births throughout the study period, the impact
of pregnancy terminations after prenatal diagnosis of congen-
ital cardiac malformations is probably small. The study had
limited power (10%) to detect a meaningful decrease in birth
prevalence rates for congenital heart disease; even if all women
prenatally diagnosed (6.1% of total) chose pregnancy termina-
tion, prevalence rates would only decrease minimally to 7.6
cases/1,000 live births.
Study strengths. The data for this study came from a
well-established birth defects surveillance system (MACDP),
which ascertains all congenital cardiac malformations within a
well-deﬁned birth population, and from a single primary
pediatric cardiology provider, The Children’s Heart Center.
Because of this concentration of data in only two sources, the
collection of information regarding prenatal diagnosis was
facilitated. These two data sources allowed reliable and almost
complete linkage of all congenital cardiac malformations dur-
ing the study.
Conclusions. This study documents the increasing role of
fetal echocardiography in the prenatal diagnosis of congenital
cardiac malformations in a well deﬁned population. It also
shows that the prenatal diagnosis of congenital cardiac malfor-
mations has led to only a small number of pregnancy termina-
tions and thus has had no effect on the birth prevalence or
ultimate outcomes after diagnosis of these birth defects. Fi-
nally, it shows that the rate of prenatal diagnosis varies
considerably by the type of cardiac defect.
Prenatal diagnosis by fetal echocardiography will continue
to have a greater impact on the practice of pediatric cardiology
and the surveillance of congenital cardiac malformations in
large, well deﬁned birth populations. As earlier fetal diagnosis
of congenital cardiac malformations becomes the norm, pedi-
atric cardiologists, perinatologists and obstetricians must work
together closely to provide both mother and fetus optimal care
and support during the difﬁcult transition toward birth.
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